165 related articles for article (PubMed ID: 7559305)
1. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I.
Campbell M; Cueva JE
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1124-32. PubMed ID: 7559305
[TBL] [Abstract][Full Text] [Related]
2. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
Campbell M; Anderson LT; Green WH
J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Campbell M; Cueva JE
J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacology in childhood disorders.
Wiener JM
Psychiatr Clin North Am; 1984 Dec; 7(4):831-43. PubMed ID: 6151651
[TBL] [Abstract][Full Text] [Related]
5. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
6. Use of medication in pervasive developmental disorders.
Sloman L
Psychiatr Clin North Am; 1991 Mar; 14(1):165-82. PubMed ID: 1675463
[TBL] [Abstract][Full Text] [Related]
7. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of irritability in pervasive developmental disorders.
Stigler KA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
[TBL] [Abstract][Full Text] [Related]
9. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic drug therapy in children and adolescents.
Wiener JM
Psychosomatics; 1982 May; 23(5):488-91, 494-5. PubMed ID: 6125987
[No Abstract] [Full Text] [Related]
11. Anxiolytics, adrenergic agents, and naltrexone.
Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
[TBL] [Abstract][Full Text] [Related]
12. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
Correll CU; Kratochvil CJ; March JS
J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
[TBL] [Abstract][Full Text] [Related]
13. Clonidine: diverse use in pharmacologic management.
Dowben JS; Grant JS; Keltner NL
Perspect Psychiatr Care; 2011 Apr; 47(2):105-8. PubMed ID: 21426356
[No Abstract] [Full Text] [Related]
14. Current concepts. Psychopharmacology in children.
Biederman J; Jellinek MS
N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421
[No Abstract] [Full Text] [Related]
15. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Weller EB; Rowan A; Elia J; Weller RA
J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
[TBL] [Abstract][Full Text] [Related]
16. [The use of psychopharmaceutical agents in children].
Minderaa RB; Intveld AN; Vink HJ
Ned Tijdschr Geneeskd; 1989 Feb; 133(5):252-6. PubMed ID: 2927536
[No Abstract] [Full Text] [Related]
17. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
18. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
19. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
